SouthState’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
SouthState's CRL Position: Q3 2026 in Review
SouthState held its Charles River Laboratories (CRL) position steady in Q3 2026 at 15 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #839.
SouthState first reported a position in CRL in Q2 2022 and has held it in 9 quarters since. The position peaked at $11.9K in Q1 2025. 522 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- SouthState held 15 shares of Charles River Laboratories worth $4.43K as of Q3 2026.
- SouthState left its Charles River Laboratories share count unchanged in Q3 2026.
- Charles River Laboratories made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #839 holding.
- SouthState first reported a position in Charles River Laboratories in Q2 2022 and has held it in 9 quarters since.
- SouthState's Charles River Laboratories position peaked at $11.9K in Q1 2025.
- 522 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.